Therefore, we examined several proteins with known involvement in the PI3K/AKT/mTOR signaling pathway, as well as others that are known to be aberrant in animal models of Fragile X syndrome, tuberous sclerosis, and PTEN deficiency. This evidence concerns the gene AKT1 and fragile X syndrome.